Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar … Read more
Epigral Ltd. (EPIGRAL) - Total Assets
Latest total assets as of September 2025: ₹32.36 Billion INR
Based on the latest financial reports, Epigral Ltd. (EPIGRAL) holds total assets worth ₹32.36 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Epigral Ltd. - Total Assets Trend (2015–2025)
This chart illustrates how Epigral Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Epigral Ltd. - Asset Composition Analysis
Current Asset Composition (March 2025)
Epigral Ltd.'s total assets of ₹32.36 Billion consist of 24.6% current assets and 75.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0.6% |
| Accounts Receivable | ₹2.32 Billion | 7.4% |
| Inventory | ₹3.88 Billion | 12.3% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹187.30 Million | 0.6% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Epigral Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Epigral Ltd.'s current assets represent 24.6% of total assets in 2025, an increase from 15.9% in 2015.
- Cash Position: Cash and equivalents constituted 0.6% of total assets in 2025, up from 0.1% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 12.3% of total assets.
Epigral Ltd. Competitors by Total Assets
Key competitors of Epigral Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dawood Hercules Corporation Ltd
KAR:DAWH
|
Pakistan | PKRs781.72 Billion |
|
Fauji Fertilizer Bin Qasim Ltd
KAR:FFBL
|
Pakistan | PKRs203.28 Billion |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
China | CN¥24.47 Billion |
|
Jiangsu Wujiang China Eastern Silk Market Co Ltd
SHE:000301
|
China | CN¥212.80 Billion |
|
Zangge Holding Co Ltd
SHE:000408
|
China | CN¥16.36 Billion |
|
Sichuan Jinlu Group Co Ltd
SHE:000510
|
China | CN¥2.53 Billion |
|
Jilin Gpro Titanium Industry Co Ltd
SHE:000545
|
China | CN¥2.48 Billion |
|
Aoyuan Beauty Valley Technology Co Ltd
SHE:000615
|
China | CN¥2.74 Billion |
Epigral Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Epigral Ltd. generates 0.81x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Epigral Ltd. generates $ 11.35 in net profit.
Epigral Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.31 | 0.79 | 0.47 |
| Quick Ratio | 0.63 | 0.40 | 0.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹1.58 Billion | ₹ -1.74 Billion | ₹ -2.07 Billion |
Epigral Ltd. - Advanced Valuation Insights
This section examines the relationship between Epigral Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.93 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | ₹31.52 Billion |
| Market Capitalization | $131.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Epigral Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Epigral Ltd.'s assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Epigral Ltd. (2015–2025)
The table below shows the annual total assets of Epigral Ltd. from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹31.52 Billion | +12.82% |
| 2024-03-31 | ₹27.94 Billion | +14.89% |
| 2023-03-31 | ₹24.32 Billion | +14.53% |
| 2022-03-31 | ₹21.24 Billion | +46.59% |
| 2021-03-31 | ₹14.49 Billion | +13.76% |
| 2020-03-31 | ₹12.73 Billion | +21.95% |
| 2019-03-31 | ₹10.44 Billion | +55.66% |
| 2018-03-31 | ₹6.71 Billion | +27.16% |
| 2017-03-31 | ₹5.28 Billion | -2.28% |
| 2016-03-31 | ₹5.40 Billion | +1.06% |
| 2015-03-31 | ₹5.34 Billion | -- |